Most Popular
-
1
Dongduk Women’s University halts coeducation talks
-
2
Russia sent 'anti-air' missiles to Pyongyang, Yoon's aide says
-
3
Defense ministry denies special treatment for BTS’ V amid phone use allegations
-
4
OpenAI in talks with Samsung to power AI features, report says
-
5
Two jailed for forcing disabled teens into prostitution
-
6
South Korean military plans to launch new division for future warfare
-
7
Gold bars and cash bundles; authorities confiscate millions from tax dodgers
-
8
Teen smoking, drinking decline, while mental health, dietary habits worsen
-
9
Kia EV9 GT marks world debut at LA Motor Show
-
10
North Korean leader ‘convinced’ dialogue won’t change US hostility
South Korea's molecular diagnostics company Seegene Inc. said Tuesday it has exported 5.1 million COVID-19 test kits to Israel.
The company already delivered 1.7 million diagnostic tests last month and is scheduled to deliver an additional 3.4 million tests kits this month.
Israel has recently experienced a shortage of COVID-19 tests amid the fast spread of the omicron variant and an unprecedented surge in new cases following the winter flu season.
Seegene said its delivery of COVID-19 diagnostic tests is expected to cover approximately 57 percent of Israel's 9 million population.
"We will continue to support countries in need of COVID-19 tests to improve global health," said CEO Chun Jong-Yoon said in a press release.
Seegene said it will deliver various COVID-19 test kits to Israel, including two models that can quickly determine the omicron variant in real time and distinguish between influenza virus and COVID-19.
The Israeli health authorities announced 27,167 new COVID-19 cases Sunday, raising the country's total number of infections to 1,785,551. (Yonhap)
The company already delivered 1.7 million diagnostic tests last month and is scheduled to deliver an additional 3.4 million tests kits this month.
Israel has recently experienced a shortage of COVID-19 tests amid the fast spread of the omicron variant and an unprecedented surge in new cases following the winter flu season.
Seegene said its delivery of COVID-19 diagnostic tests is expected to cover approximately 57 percent of Israel's 9 million population.
"We will continue to support countries in need of COVID-19 tests to improve global health," said CEO Chun Jong-Yoon said in a press release.
Seegene said it will deliver various COVID-19 test kits to Israel, including two models that can quickly determine the omicron variant in real time and distinguish between influenza virus and COVID-19.
The Israeli health authorities announced 27,167 new COVID-19 cases Sunday, raising the country's total number of infections to 1,785,551. (Yonhap)
